PhaseRx, Inc.
OTC: PZRXQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Robert W. Overell
- Employees
- 10
- Headquarters
- Seattle, United States
- IPO year
- 2016
- Market cap
- $1.2K
- Website
- https://www.phaserx.com
Loading PZRXQ…
Loading profile data…Frequently asked questions about PZRXQ
What does PhaseRx, Inc. (PZRXQ) do?
PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments for inherited enzyme deficiencies affecting the liver. Its therapeutic strategy involves intracellular enzyme replacement, powered by its unique Hybrid mRNA technology platform, which facilitates the production of absent enzymes directly within the body's cells. The...
Where does PZRXQ trade?
PhaseRx, Inc. (PZRXQ) trades on the Other OTC.
What sector is PZRXQ in?
PhaseRx, Inc. (PZRXQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of PhaseRx, Inc.?
Robert W. Overell is the chief executive officer of PhaseRx, Inc. (PZRXQ).
Where is PhaseRx, Inc. headquartered?
PhaseRx, Inc. is headquartered in United States.
Does PZRXQ pay a dividend?
PhaseRx, Inc. (PZRXQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PZRXQ go public?
PhaseRx, Inc. (PZRXQ) completed its initial public offering in 2016.